Literature DB >> 16436010

Obesity, breast cancer and the role of adipocytokines.

Tanvir Kaur1, Zuo-Feng Zhang.   

Abstract

Obesity is a worldwide problem which impacts the risk and prognosis of some of the more common forms of cancer, including breast cancer in post-menopausal women. As the basis for understanding the potential mechanisms of obesity and cancer relationship has advanced, a number of new hypotheses have emerged. The adipocytokines are a complex group of biologically active polypeptides. Leptin is a growth hormone, secreted by adipose tissue, whose levels are normally elevated in obese individuals and may have a promoting effect on carcinogenesis and metastasis of breast cancer, possibly in an autocrine manner. Leptin interferes with the insulin signaling pathway and in type 2 diabetes plasma leptin levels are found to be correlated with the degree of insulin resistance, a relationship independent of body mass. This relationship might provide a mechanistic explanation for promotion potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16436010

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Metabolic effects of obesity: A review.

Authors:  Parul Singla; Animesh Bardoloi; Anuj A Parkash
Journal:  World J Diabetes       Date:  2010-07-15

2.  Association of overweight and obesity with breast cancer in India: scope for improvement.

Authors:  Sushama Subhash Thakre; Subhash Bapuraoji Thakre
Journal:  Indian J Community Med       Date:  2014-10

3.  The Effects of Reduction Mammaplasty on Serum Leptin Levels and Insulin Resistance.

Authors:  Hakan Uzun; Ozan Bitik; Yahya Baltu; Çiğdem Sönmez; Ayşegül Öztürk Kaymak
Journal:  Int J Endocrinol       Date:  2015-10-13       Impact factor: 3.257

4.  Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer.

Authors:  Mohamed Hosney; Salwa Sabet; Mohamed El-Shinawi; Khadiga M Gaafar; Mona M Mohamed
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.